Jack Hoblitzell, PhD
Senior Vice President, Pharmaceutical Development at Botanix Pharmaceuticals- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Lynn F. Palmer
Jack is a practical and effective Pharmaceutical Development executive. He has effectively led the development of multiple formulations, and scaled them up to commercial scale. He has extensive industry and technical knowledge of formulation development, product stability, pharmaceutical packaging, and equipment capability and setup. I strongly endorse him.
Lynn F. Palmer
Jack is a practical and effective Pharmaceutical Development executive. He has effectively led the development of multiple formulations, and scaled them up to commercial scale. He has extensive industry and technical knowledge of formulation development, product stability, pharmaceutical packaging, and equipment capability and setup. I strongly endorse him.
Lynn F. Palmer
Jack is a practical and effective Pharmaceutical Development executive. He has effectively led the development of multiple formulations, and scaled them up to commercial scale. He has extensive industry and technical knowledge of formulation development, product stability, pharmaceutical packaging, and equipment capability and setup. I strongly endorse him.
Lynn F. Palmer
Jack is a practical and effective Pharmaceutical Development executive. He has effectively led the development of multiple formulations, and scaled them up to commercial scale. He has extensive industry and technical knowledge of formulation development, product stability, pharmaceutical packaging, and equipment capability and setup. I strongly endorse him.
Experience
-
Botanix Pharmaceuticals
-
Australia
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Senior Vice President, Pharmaceutical Development
-
Sep 2021 - Present
Responsible for CMC and pharmaceutical development activities. Responsible for CMC and pharmaceutical development activities.
-
-
-
-
Sr. Vice President, Technical Operations
-
May 2020 - Jun 2021
Management of all Technical Operations (CMC, Manufacturing, Supply Chain and Quality) functions resulting from the merger of Assertio Therapeutics and Zyla Life Sciences, in May 2020. Executive Leadership Team Member, reporting to CEO. Management of all Technical Operations (CMC, Manufacturing, Supply Chain and Quality) functions resulting from the merger of Assertio Therapeutics and Zyla Life Sciences, in May 2020. Executive Leadership Team Member, reporting to CEO.
-
-
-
-
Vice President, Technical Operations
-
Jun 2015 - May 2020
Directed manufacturing and supply chain activities for all commercial products at contract manufacturing organizations. Successfully managed the product launch activities for Arymo ER Tablets. Directed manufacturing and supply chain activities for all commercial products at contract manufacturing organizations. Successfully managed the product launch activities for Arymo ER Tablets.
-
-
-
Purdue Pharmaceuticals
-
United States
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Director, Pharmaceutical Technology Services
-
Dec 2013 - May 2015
Responsible for directing manufacturing technology transfer activity, both internal and external, as well as technical support to the manufacturing operations. Liaison with R&D group for new product development, validation and product launch. Responsible for directing manufacturing technology transfer activity, both internal and external, as well as technical support to the manufacturing operations. Liaison with R&D group for new product development, validation and product launch.
-
-
-
-
Senior Consultant
-
Sep 2012 - Dec 2013
Provided consulting services to pharmaceutical companies related to operational excellence, technical services, validation, compliance, regulatory and quality systems in the areas of manufacturing and packaging. Provided consulting services to pharmaceutical companies related to operational excellence, technical services, validation, compliance, regulatory and quality systems in the areas of manufacturing and packaging.
-
-
-
Pfizer
-
Events Services
-
1 - 100 Employee
-
Sr. Director, Pharm. Tech., Global Manufacturing Services | Pfizer Global Supply
-
Mar 2011 - Sep 2012
Responsible for integration of King Pharmaceutical products and processes into the Pfizer co-development and manufacturing supply networks. Responsible for integration of King Pharmaceutical products and processes into the Pfizer co-development and manufacturing supply networks.
-
-
-
King Pharmaceuticals
-
Pharmaceutical Manufacturing
-
200 - 300 Employee
-
Sr. Director, Pharmaceutical Technology
-
Sep 2008 - Sep 2012
Implemented and transferred new technologies and products into the King Technical Operations network, including CMOs. Acted as key liaison with R&D to assure new products developed are manufacturing friendly (cost effective, robust and optimized). Provided technical oversight and support of currently marketed products. CMC team leader for the Aversion products. Implemented and transferred new technologies and products into the King Technical Operations network, including CMOs. Acted as key liaison with R&D to assure new products developed are manufacturing friendly (cost effective, robust and optimized). Provided technical oversight and support of currently marketed products. CMC team leader for the Aversion products.
-
-
-
-
Associate Director, Formulation & Process Development, Pharmaceutical Development Services
-
2008 - 2008
Contract development organization - Contract manufacturing organization Staff recruitment, selection and onboarding Business development and customer relations on projects Contract development organization - Contract manufacturing organization Staff recruitment, selection and onboarding Business development and customer relations on projects
-
-
-
-
Director, Formulations Development & Biopharmaceutics
-
2006 - 2007
Formulation development and biopharmaceutical responsibilities for development of internal “value-added” products, as well as, client soft gelatin capsule products. API sourcing strategy for new products. Support business development activities for successful product out-licensing. Formulation development and biopharmaceutical responsibilities for development of internal “value-added” products, as well as, client soft gelatin capsule products. API sourcing strategy for new products. Support business development activities for successful product out-licensing.
-
-
Education
-
University of Rhode Island
PhD, Pharmaceutics -
University of Rhode Island
Bachelor of Science, Pharmacy